BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12849808)

  • 1. Differential effects of unopposed versus opposed hormone therapy, tibolone, and raloxifene on substance p levels.
    Kukuvitis A; Kourtis A; Papaiconomou N; Zournatzi V; Makedos G; Panidis D
    Fertil Steril; 2003 Jul; 80(1):96-8. PubMed ID: 12849808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
    Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Creatsa MG; Economou EV; Siasou Z; Panoulis CP; Kalligerou I; Papadias C
    Climacteric; 2008 Apr; 11(2):155-65. PubMed ID: 18365858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
    J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tibolone on plasma homocysteine levels in postmenopausal women.
    Celik H; Ayar A; Tug N; Cikim G; Kilic N; Parmaksiz C
    Fertil Steril; 2002 Aug; 78(2):347-50. PubMed ID: 12137873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Papadias C; Sarandakou A; Liakakos T; Alexandrou A; Creatsas G
    Eur J Endocrinol; 2004 Aug; 151(2):187-92. PubMed ID: 15296473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys.
    Register TC; Wagner JD; Zhang L; Hall J; Clarkson TB
    Menopause; 2002; 9(6):411-21. PubMed ID: 12439100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of different hormone treatment on endothelial function in healthy postmenopausal women.
    Akman L; Duygu H; Akercan F; Ulukus M; Ozerkan F; Akin M
    Gynecol Endocrinol; 2013 Sep; 29(9):867-72. PubMed ID: 23875965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
    Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipids and apolipoproteins in Greek postmenopausal women: association with estrogen, estrogen-progestin, tibolone and raloxifene therapy.
    Creatsas G; Christodoulakos G; Lambrinoudaki I; Panoulis C; Chondros C; Patramanis P
    J Endocrinol Invest; 2003 Jun; 26(6):545-51. PubMed ID: 12952369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.
    Shadoan MK; Anthony MS; Rankin SE; Clarkson TB; Wagner JD
    Metabolism; 2003 Sep; 52(9):1085-91. PubMed ID: 14506611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of tibolone and conjugated equine estrogens with and without medroxyprogesterone acetate on the reproductive tract of female cynomolgus monkeys.
    Cline JM; Register TC; Clarkson TB
    Menopause; 2002; 9(4):242-52. PubMed ID: 12082360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys.
    Cline JM; Register TC; Clarkson TB
    Menopause; 2002; 9(6):422-9. PubMed ID: 12439101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
    Kiran H; Kiran G
    Arch Gynecol Obstet; 2006 Apr; 274(1):9-12. PubMed ID: 16369811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.